Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
You currently have no recent searches
An Existing Folder
A New Folder
The item(s) has been successfully added to "".
Friend's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at The Nurse Practitioner.
Send a copy to your email
Your message has been successfully sent to your friend.
Some error has occurred while processing your request. Please try after some time.
Save my selection
Collection of multiple sclerosis articles.
Nurse Practitioner. 38(4):35-36, April 10, 2013.
MS: Managing patients in primary care
Nurse Practitioner. 37(8):56, August 11, 2012.
...the death of a patient with multiple sclerosis...
Nurse Practitioner. 37(6):17, June 10, 2012.
...multiple sclerosis patients receiving natalizumab...
Nurse Practitioner. 37(3):56, March 13, 2012.
...a death within 24 hours of taking the first dose of fingolimod (Gilenya), used to treat multiple sclerosis...
Nurse Practitioner. 36(11):56, November 2011.
...urinary incontinence due to overactive bladder in patients with spinal cord injuries or multiple sclerosis...
Nurse Practitioner. 36(1):56, January 2011.
The FDA approved fingolimod (Gilenya) 0.5 mg capsules to reduce relapses and delay disability progression in patients with the relapsing form of multiple sclerosis.
Belavic, Jennifer M.
Belavic, Jennifer M. Less
Nurse Practitioner. 35(11):7-9, November 2010.
Multiple sclerosis (MS) affects approximately 400,000 Americans and 2.5 million adults worldwide.
Savely, Virginia Less
Nurse Practitioner. 35(7):44-50, July 2010.
Multiple Sclerosis (MS). The magnetic resonance imaging scans of patients with disseminated LD and patients with MS are indistinguishable, each revealing white plaques in the gray matter.
Nurse Practitioner. 35(4):56, April 2010.
The FDA approved dalfampridine (Ampyra), an oral timed-release
tablet, to improve walking in patients with multiple sclerosis.
Nurse Practitioner. 34(11):56, November 2009.
The FDA approved interferon beta-1b (Extavia) for the treatment of relapsing forms of multiple sclerosis.
Oliver, Brant J.
Oliver, Brant J. Less
Nurse Practitioner. 34(9):10-14, September 2009.
Primary care management of fatigue and relapses in RRMS.
Nurse Practitioner. 33(11):56, November 2008.
The FDA notified healthcare professionals of two new cases of progressive multifocal leukoencephalopathy (PML) in European patients receiving natalizumab (Tysabri) monotherapy for multiple sclerosis (MS) for more than 1 year.
Nurse Practitioner. 33(10):56, October 2008.
The FDA issued an alert to healthcare practitioners about additional recommendations for cardiac monitoring of patients with multiple sclerosis (MS) who are treated with mitoxantrone (Novantrone).
Nurse Practitioner. 29(1):54, January 2004.
...the John Dystel Nursing Fellowship in MS is a training opportunity for nurses to learn the skills necessary to provide
the highest quality of specialized multiple sclerosis (MS) nursing care.
Nurse Practitioner. 28(8):50-51, August 2003.
Biogen has received FDA approval of interferon beta-1a (Avonex) for the treatment of patients who have suffered a first multiple sclerosis (MS) attack if brain MRI abnormalities characteristic of MS are indicated.
Stay up-to-date! Be notified every time a new item is added. Receive an Email or subscribe to an RSS feed.